Skip to content

An observational clinical research of personalized medicine for cancer patients based on organoid technology

An observational clinical research of personalized medicine for cancer patients based on organoid technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059144
Enrollment
Unknown
Registered
2022-04-26
Start date
2022-04-26
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor

Interventions

Case Series:Nil

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged range from 18 to 75 years; 2. Confirmed solid tumor patients; 3. The foci (primary foci > 1.0cm in diameter) were measured according to RECIST criteria; 4. Tumor patients can be surgically removed after clinical diagnosis, and sufficient tissue (>=1.0cm^3) can be obtained from primary lesions or metastatic lesions for organoid culture and histological analysis; 5. Patients will receive chemotherapy or targeted drugs after surgical resection of tumor lesions; 6. ECOG score (PS) =6 months; 8. Normal function of major organs.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients; 2. Patients with peripheral nervous system disorders caused by diseases or with a clear history of mental disorders and central nervous system disorders; 3. Patients with severe infection or active digestive tract ulcers need treatment; 4. Severe liver disease (such as cirrhosis), cardiovascular disease, kidney disease, respiratory disease, blood system disease, or uncontrolled diabetes.

Design outcomes

Primary

MeasureTime frame
Area under the curve of drug-response curve;Objective response rate;

Countries

China

Contacts

Public ContactZhao Qingwei
qwzhao@zju.edu.cn+86 571 87236560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026